Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence.

Obesity (Silver Spring) · 2023 · PMC12398307 · PMID 36998152

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

modestly significantno p-value reported

Correlations of the change in body weight during GLP-1RA treatment We found a modestly significant correlation of weight loss (percentage) of pre-MBS weight to post-MBS nadir weight and weight loss (percentage) after 12 months of GLP-1RA treatment with semaglutide and liraglutide ( r = 0.206, p = 0.035; Figure 4A ).

also in 46 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.